| Recruitment status | No longer recruiting |
| Unique ID issued by UMIN | UMIN000022026 |
| Receipt No. | R000024965 |
| Official scientific title of the study | Influence of probiotics on the gastric microbiota in functional dyspepsia |
| Date of disclosure of the study information | 2016/04/23 |
| Last modified on | 2016/04/22 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Influence of probiotics on the gastric microbiota in functional dyspepsia | |
| Title of the study (Brief title) | Influence of probiotics on the gastric microbiota in functional dyspepsia | |
| Region |
|
|
| Condition | ||||
| Condition | Functional dyspepsia | |||
| Classification by specialty |
|
|||
| Classification by malignancy | Others | |||
| Genomic information | NO | |||
| Objectives | |
| Narrative objectives1 | To target the Functional dyspepsia patients, gastric juice flora and its configuration comprehensively analyzed by gene base sequence measurement methods such as 16SrRNA gene, further clarify the effect of the gastric juice flora of probiotic administration to. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Healthy subjects and FD patients of gastric juice flora and gastric juice flora of probiotic administration after 12 weeks |
| Key secondary outcomes | FSSG score
serum PG1,2 sucrose permeability test |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Lactbacillus gasseri OLL 2716 * 1000000000 CFU content of yogurt is administered one a day for 12 weeks | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Diagnosis of FD by the RomeIII criteria | |||
| Key exclusion criteria | Have proton pump inhibitor administration.
After gastrectomy. Have an allergy to lactic acid bacteria formulation. Antimicrobial used within one month. H. pylori-infected persons. |
|||
| Target sample size | 60 | |||
| Research contact person | |
| Name of lead principal investigator | Yasuhiro Koga |
| Organization | Tokai University school of Medicine |
| Division name | Basic Medical Sciences, biological defense science |
| Address | Isehara, Kanagawa Prefecture Shimokasuya 143 |
| TEL | 0463-93-1121 |
| yasuhiro@is.icc.u-tokai.ac.jp | |
| Public contact | |
| Name of contact person | Hirohiko Nakae |
| Organization | Tokai University School of Medicine |
| Division name | Gastroenterological medicine |
| Address | Isehara, Kanagawa Prefecture Shimokasuya 143 |
| TEL | 0463-93-1121 |
| Homepage URL | |
| nka.1425@gmail.com | |
| Sponsor | |
| Institute | Self funding |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | Self funding
|
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | No longer recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000024965 |